Pfizer COVID vaccine under EMA review for younger teens
The Pharma Data
MAY 3, 2021
The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . Pfizer also shared antibody responses from the younger age group.
Let's personalize your content